Protéus is a biotechnology company specialized in the design, development and implementation of sustainable industrial processes using enzymes / biocatalysts and microbial strains. To fulfill this mission, Protéus benefits from a portfolio of proprietary technologies including a collection of exclusive microbial biodiversity, technologies for enzymes engineering and microbial strains optimization, and a platform of enzyme production and formulation to turn them into industrial tools. As a member of PCAS group, a fine chemical company developing processes and producing complex molecules for Life Sciences and Specialty Chemicals Markets, Protéus also benefits from the industrial capabilities and expertise of the Group. The PCAS Group is listed on Nyse Euronext Compartment C.
Protéus is a biotechnology company specialized in the design, development and implementation of sustainable industrial processes using enzymes / biocatalysts and microbial strains. To fulfill this mission, Protéus benefits from a portfolio of proprietary technologies including a collection of exclusive microbial biodiversity, technologies for enzymes engineering and microbial strains optimization, and a platform of enzyme production and formulation to turn them into industrial tools. As a member of PCAS group, a fine chemical company developing processes and producing complex molecules for Life Sciences and Specialty Chemicals Markets, Protéus also benefits from the industrial capabilities and expertise of the Group. The PCAS Group is listed on Nyse Euronext Compartment C.